首页> 外文OA文献 >Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study

【2h】

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study

机译：CT-P13（BioSimilar Flowiximab）在类风湿性关节炎患者中的功效和安全性：从Planetra延伸研究中的CT-P13切换到CT-P13的切换与Planetra延伸研究中的持续CT-P13的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Dae Hyun Yoo; Nenad Prodanovic; Janusz Jaworski; Pedro Miranda; Edgar Ramiterre; Allan Lanzon; Asta Baranauskaite; Piotr Wiland; Carlos Abud-Mendoza; Boycho Oparanov; Svitlana Smiyan; HoUng Kim; Sang Joon Lee; SuYeon Kim; Won Park;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study [J] . Yoo Dae Hyun, Prodanovic Nenad, Jaworski Janusz, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2017 ,第2期

机译：CT-P13（BioSimilarIngiximab）在类风湿性关节炎患者中的功效和安全性：从Planetra延伸研究中的CT-P13切换到CT-P13的切换与Planetra延伸研究中的持续CT-P13的比较
2. Switching from the infliximab reference product to CT-P13 in patients with rheumatoid arthritis or ankylosing spondylitis: results of the PLANETAS and PLANETRA extension studies [J] . GaBI?Online?Editor GaBi journal. . 2016 ,第2期

机译：类风湿关节炎或强直性脊柱炎患者从英夫利昔单抗参考产品转换为CT-P13：PLANETAS和PLANETRA扩展研究的结果
3. A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study [J] . Dae Hyun Yoo, Artur Racewicz, Jan Brzezicki, Arthritis research & therapy. . 2016 ,第1期

机译：III期随机研究评估活动性类风湿性关节炎患者CT-P13与英夫利昔单抗的疗效和安全性：PLANETRA研究的54周结果
4. Human Antichimeric Antibodies to Infliximab and Infusion-Related Allergic Reactions in Patients with Rheumatoid Arthritis [C] . D. Wouters, S. Stapel, M. Vis, Collegium Internationale Allergologicum . 2007

机译：人的苯甲酸纤维化率和类风湿性关节炎患者的infumency相关过敏反应的抗体抗体
5. A Cost-utility Analysis of Biosimilar Infliximab Compared to Reference Infliximab in Adult Switch Patients with Crohn's Disease: A Canadian Analysis [D] . Hughes, Avery. 2018

机译：生物纤维生素infiximab的成本实用性分析与成人交换患者参考incriximab患者克罗恩病患者：加拿大分析
6. Extended report: Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study [O] . Dae Hyun Yoo, Nenad Prodanovic, Janusz Jaworski, -1

机译：扩展报告：类风湿关节炎患者中CT-P13（生物仿制药英夫利昔单抗）的疗效和安全性：在PLANETRA扩展研究中从参考英夫利昔单抗转换为CT-P13与持续进行CT-P13之间的比较
7. A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study [O] . 2016

机译：III期随机研究评估活动性类风湿性关节炎患者CT-P13与英夫利昔单抗的疗效和安全性：PLANETRA研究的54周结果

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study

著录项

相似文献

相关主题

期刊订阅